Search - tctmd.com

Displaying 21 - 40 of 1806

Sort: Relevancy | Date

Presentation THT 2026

The Landscape of Devices Under Development for Percutaneous Mechanical Support

Presenter: Ajay J. Kirtane

March 03, 2026

Presentation THT 2026

LVADs to Jumpstart the Process of Myocardial Regeneration

Presenter: Stavros G. Drakos

March 02, 2026

Presentation THT 2026

The CHILD Trial: Phase I Randomized Study of Cardiac Stem Cells in Patients with Hypoplastic Left Heart Syndrome

Presenter: Sunjay Kaushal

March 02, 2026

Presentation THT 2026

Implantation of iPS Cells Differentiated into Cardiomyocytes to Repair the Damaged Myocardium

Presenter: Eugene Jiaxian Wang

March 02, 2026

Presentation THT 2026

Cardiac Reprogramming Cocktail Delivered in a Single Adeno-Associated Virus to Improve Function in a Porcine Model of Ischemic Heart Failure

Presenter: Kathy Ivey

March 02, 2026

Presentation THT 2026

Inducing Cardiomyocyte Proliferation Using Native Cell Cycle Pathways to Create More Cardiomyocytes

Presenter: James F. Martin

March 02, 2026

Presentation THT 2026

Treating Danon Disease with Gene Therapy: Lessons Learned and Prospects for the Future

Presenter: Eric D. Adler

March 02, 2026

Presentation THT 2026

Overview of Gene Therapies for Specific Cardiomyopathies

Presenter: Barry Greenberg

March 02, 2026

News Conference News THT 2026

THT 2026: What to Expect in Boston

Todd Neale

February 23, 2026

News Daily News

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

Michael O'Riordan

February 19, 2026

News Opinion Off Script

Why Interventionalists Must Work Toward Global Cardiovascular Equity

Tesfaye Telila, MD

February 17, 2026

News Daily News

Meta-analysis Teases Out What Drives Success in M-TEER

Caitlin E. Cox

February 10, 2026

News Daily News

Cardioprotective Flush, Without Reanimation, Safe and Effective in DCD Transplant

Michael O'Riordan

January 28, 2026

News Daily News

HF Care Differs Among Asian Subgroups in the US

L.A. McKeown

January 16, 2026

News Daily News

TV Shows Often Fumble When Portraying CPR

Michael O'Riordan

January 14, 2026

News Daily News

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

Caitlin E. Cox

December 31, 2025

News Daily News

Déjà Vu All Over Again? Results of Intracoronary Stem Cell Study Questioned

Yael L. Maxwell

November 13, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2025

Caitlin E. Cox

November 03, 2025

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

Presentation TCT 2025

Left Atrial Appendage Occlusion - Expanding Indications and Controversies

Presenter: Josep Rodés-Cabau

October 27, 2025

Advertisement

The Landscape of Devices Under Development for Percutaneous Mechanical Support

LVADs to Jumpstart the Process of Myocardial Regeneration

The CHILD Trial: Phase I Randomized Study of Cardiac Stem Cells in Patients with Hypoplastic Left Heart Syndrome

Implantation of iPS Cells Differentiated into Cardiomyocytes to Repair the Damaged Myocardium

Cardiac Reprogramming Cocktail Delivered in a Single Adeno-Associated Virus to Improve Function in a Porcine Model of Ischemic Heart Failure

Inducing Cardiomyocyte Proliferation Using Native Cell Cycle Pathways to Create More Cardiomyocytes

Treating Danon Disease with Gene Therapy: Lessons Learned and Prospects for the Future

Overview of Gene Therapies for Specific Cardiomyopathies

THT 2026: What to Expect in Boston

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

Why Interventionalists Must Work Toward Global Cardiovascular Equity

Meta-analysis Teases Out What Drives Success in M-TEER

Cardioprotective Flush, Without Reanimation, Safe and Effective in DCD Transplant

HF Care Differs Among Asian Subgroups in the US

TV Shows Often Fumble When Portraying CPR

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

Déjà Vu All Over Again? Results of Intracoronary Stem Cell Study Questioned

TCTMD’s Top 10 Most Popular Stories for October 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Left Atrial Appendage Occlusion - Expanding Indications and Controversies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content